Status:
COMPLETED
Oral Dexamethasone for Treatment of Migraine
Lead Sponsor:
The Joseph Epstein Centre for Emergency Medicine Research
Conditions:
Migraine
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The aim of this project is to determine if a single dose of oral dexamethasone at the time of discharge from the emergency department (ED) \[after successful treatment\] prevents rebound headache. Hy...
Detailed Description
Migraine headache can be a debilitating condition. A small but significant proportion of sufferers seek treatment in emergency departments \[ED\], accounting for 2-5% of ED visits.Available data sugge...
Eligibility Criteria
Inclusion
- Consenting adult patients \[age \>17 years\] with physician-diagnosed migraine treated in the ED who are willing and able to be contacted between 48-72 hours after discharge for follow-up
Exclusion
- Failure to consent
- Pregnancy
- Allergy to study medication
- Findings inconsistent with migraine
- Patients requiring hospital admission for further investigation and treatment
- Patients with active peptic ulcer disease
- Patients with Type 1 diabetes
- Patients taking corticosteroids for another condition within 7 days
- Active systemic fungal infection
- Patients previously enrolled in the study
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2007
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT00216736
Start Date
April 1 2005
End Date
July 1 2007
Last Update
April 30 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Emergency Medicine, Western Health
Melbourne, Victoria, Australia, 3011